Corrigendum 'Diselenide-crosslinked carboxymethyl chitosan nanoparticles for doxorubicin delivery: Preparation and in vivo evaluation' [Carbohydr. Polym. 292(2022):119699
机构：[1]School of Medicine, Foshan University, Foshan 528000, Guangdong, PR China.[2]Department of Statistics, University of California, Riverside, 900 University Ave., Riverside, CA 92521, USA.[3]School of Medicine, Foshan University, Foshan 528000, Guangdong, PR China. Electronic address: dliu@fosu.edu.cn.[4]Hospital of Chinese Traditional Medicine of Guangdong Province, Foshan 528000, Guangdong, PR China. Electronic address: zhb6541@163.com.
第一作者机构：[1]School of Medicine, Foshan University, Foshan 528000, Guangdong, PR China.
推荐引用方式(GB/T 7714)：
Wang Jun,Liu Justin,Lu Dao-Qiang,et al.Corrigendum 'Diselenide-crosslinked carboxymethyl chitosan nanoparticles for doxorubicin delivery: Preparation and in vivo evaluation' [Carbohydr. Polym. 292(2022):119699[J].Carbohydrate polymers.2023,311:120783.doi:10.1016/j.carbpol.2023.120783.
APA：
Wang Jun,Liu Justin,Lu Dao-Qiang,Chen Lijing,Yang Rujia...&Zhang Bin.(2023).Corrigendum 'Diselenide-crosslinked carboxymethyl chitosan nanoparticles for doxorubicin delivery: Preparation and in vivo evaluation' [Carbohydr. Polym. 292(2022):119699.Carbohydrate polymers,311,
MLA：
Wang Jun,et al."Corrigendum 'Diselenide-crosslinked carboxymethyl chitosan nanoparticles for doxorubicin delivery: Preparation and in vivo evaluation' [Carbohydr. Polym. 292(2022):119699".Carbohydrate polymers 311.(2023):120783
化学